Header Logo

Connection

DAVID SHEIKH-HAMAD to Vancomycin

Back to Details
This is a "connection" page, showing publications DAVID SHEIKH-HAMAD has written about Vancomycin.
DAVID SHEIKH-HAMAD
Connection Strength
0.051
Vancomycin
  1. Drug development studies supporting zileuton as a parenteral adjuvant to attenuate antibiotic-associated nephrotoxicity. Antimicrob Agents Chemother. 2025 08 06; 69(8):e0028725.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.